statisticians

Moving from SAS to R – Practical Tips Part 1

The use of R in the pharmaceutical and healthcare industry has been increasing over the years, with larger companies like Roche adopting it as their primary statistical software. Others like GSK, NovoNordisk, and Merck make heavy investments into it.  In this episode, Thomas Neitmann discusses various lessons from his career within pharma and the role …

Moving from SAS to R – Practical Tips Part 1 Read More »

The 15% Threshold in Germany and Why You Should Care

The healthcare industry is constantly developing, and with it come new regulations and guidelines that businesses must adhere to. One regulation that has recently been set in Germany is the 15% threshold for relevant improvement for some endpoints used in clinical trials. Many have critiqued this threshold. It’s important for all statisticians (not only for …

The 15% Threshold in Germany and Why You Should Care Read More »

Behind the scenes of The Effective Statistician

Podcasts have become a popular form of media for sharing information, telling stories, and building an audience. But have you ever wondered what goes on behind the scenes of creating a successful podcast? Today, I have the pleasure of sitting down with Reine Escalona and Kacey Tunac, the podcast production and management team called VVS, …

Behind the scenes of The Effective Statistician Read More »

Driving Statistical Innovation – Barriers And Strategies Part 2

In part 1 of this series, we explored the perspectives on commercializing statistical inventions, leveraging external resources, collaboration, and setting up a community of statistical methodology leaders. Innovation is essential for advancing drug development, and statisticians play a vital role in driving statistical innovation. However, to overcome the barriers to innovation, statisticians need to work together, …

Driving Statistical Innovation – Barriers And Strategies Part 2 Read More »

Driving Statistical Innovation – Barriers And Strategies Part 1

Statistical innovation is vital in the pharmaceutical industry as it drives evidence-based decisions and brings value to patients. However, it requires a delicate balance between invention and commercialization to achieve success. I, together with Mouna Akacha and Kaspar Rufibach – two leaders of statistical innovation groups in big pharma companies, share their insights on the …

Driving Statistical Innovation – Barriers And Strategies Part 1 Read More »